Division of Pediatric Cardiology, Morgan Stanley Children's Hospital of New York-Presbyterian, Columbia University Irving Medical Center, New York, New York, USA.
Division of Cardiothoracic Surgery, Morgan Stanley Children's Hospital of New York-Presbyterian, Columbia University Irving Medical Center, New York, New York, USA.
J Am Coll Cardiol. 2022 Jun 7;79(22):2247-2258. doi: 10.1016/j.jacc.2021.08.082.
The field of congenital interventional cardiology has experienced tremendous growth in recent years. Beginning with the development of early devices for transcatheter closure of septal defects in the 1970s and 1980s, such technologies have evolved to become a mainstay of treatment for many atrial septal defects (ASDs) and ventricular septal defects (VSDs). Percutaneous device closure is now the preferred approach for the majority of secundum ASDs. It is also a viable treatment option for selected VSDs, though limitations still exist. In this review, the authors describe the current state of transcatheter closure of ASDs and VSDs in children and adults, including patient selection, procedural approach, and outcomes. Potential areas for future evolution and innovation are also discussed.
近年来，先天性介入心脏病学领域取得了巨大的发展。从 20 世纪 70 年代和 80 年代早期经导管封堵室间隔缺损的早期设备开始，这些技术已经发展成为许多房间隔缺损（ASD）和室间隔缺损（VSD）的主要治疗方法。经皮器械封堵术现在已成为大多数继发 ASD 的首选方法。对于某些选择的 VSD，它也是一种可行的治疗选择，但仍存在局限性。在这篇综述中，作者描述了儿童和成人经导管 ASD 和 VSD 封堵的现状，包括患者选择、手术方法和结果。还讨论了未来可能的发展和创新领域。
